Miramistin vaginal suppositories 15 mg

Miramistin vaginal suppositories 15 mg

To favorites
Miramistin vaginal suppositories has a wide spectrum of antimicrobial activity, including hospital strains resistant to antibiotics, has an antifungal effect
Active substance:Benzyldimethyl-myristoylamino-propylammonium
Pharmacological group:Antimicrobial
Formulation:vaginal suppositories
Pills in 1 package:10
In stock

Instructions for Miramistin vaginal suppositories 15 mg

ATC codes Miramistin
D08AJ Quaternary Ammonium Compounds

Clinical-pharmacological groups / Group affiliation
Antiseptic for local use

Active substance Miramistin
benzyl-dimethyl-myristoylamino-propylammonium chloride monohydrate

Pharmaco-therapeutic group Miramistin

Antiseptic agent

Storage Conditions Miramistin
The drug should be stored in a place inaccessible to children at a temperature not higher than 25 ° C.

Best before date
The shelf life is three years. Do not use the drug after the expiry date

Brief Description Miramistin
Clinical-pharmacological group: Antiseptic for local use in gynecology.
Rectal suppositories are intended for treatment and prevention of respiratory system disorders and may be used as a photoactive agent in scope of treatment and prevention of neurological conditions.

Testimony Miramistin

  • Prevention and treatment of inflammatory diseases in gynecology (vulvovaginite, bacterial vaginosis);
  • prevention and treatment of festering postnatal injuries, vaginal wounds, and postnatal infections.

Method of use and dosage Miramistin

The suppositories are released from the contour packing prior to use.
One suppository ten mg twice a day (12 h intervals) or one suppository five mg once a day (24 h intervals) for seven days.
Apply the suppository as deeply as possible into the vagina; do not use soap or soap-based soap for genital toilet for two hours before and 2 hours after intravaginal administration of Miramistin (only clean water should be used).

Pharmacological effect Miramistin

Miramistin has a broad spectrum of antimicrobial activity, including hospital strains that are resistant to antibiotics.
The preparation has a pronounced bactericidal effect in relation to gram-positive (Staphylococcus spp., Streptococcus spp., Streptococcus pneumoniae) and gram-negative (Pseudomonas aeruginosa, Escherichia coli, Klebsiella spp.), aerobic and anaerobic bacteria, which are determined in the form of monocultures and microbial associations, including hospital strains with antibiotic polyresistance.

  • Miramistin Nosology (ICD codes)
  • A51
  • Early syphilis
  • A52
  • Late syphilis
  • A54
  • Gonococcal infection
  • A56.0
  • Chlamydia infections of the lower urinary tract
  • A56.1
  • Chlamydia infections of pelvic organs and other urinary organs
  • A59
  • Trichomoniasis
  • A60
  • Anogenital herpetic virus infection [herpes simplex]
  • Candidiasis stomatitis
  • B37.2
  • Candidiasis of the vulva and vagina
  • B37.4
  • Candidiasis of other urogenital localizations
  • N37.0
  • Urethritis in diseases classified in other headings
  • N41
  • Inflammatory disease of the uterus, except the cervix (including endometritis, myometritis, metritol, pyometra, abscess of the uterus)
  • N72
  • Inflammatory disease of the cervix (incl. cervicite, endocervicite, exocervicite)
  • N76
  • Other inflammatory diseases of the vagina and vulva
  • N77.1
  • Vaginitis, vulvite and vulvovaginitis for infectious and parasitic diseases classified in other headings
  • O08.0
  • Genital and pelvic tract infection caused by abortion, ectopic and molar pregnancy
  • O70
  • Laceration ruptures in childbirth
  • O71
  • Other obstetric injuries
Active substance
Pharmacological group
Pills in 1 package
Country of origin
Expiration Date
No reviews yet — your comment may be first.
All reviews 0
general rating
Also buying with this item
In stock
Itraconazole 100 mg
In stock
In stock
Polygynax Virgo 6 capsules
In stock